Proficiency Testing of Epidermal Growth Factor Receptor Mutations Detection in Saliva Using Spectrum Saliva Collector (SDNA-1000) and Preservative Solution Detected by Electric Field-Induced Release and Measurement
Restricted accessBrief reportFirst published online October, 2022
Proficiency Testing of Epidermal Growth Factor Receptor Mutations Detection in Saliva Using Spectrum Saliva Collector (SDNA-1000) and Preservative Solution Detected by Electric Field-Induced Release and Measurement
HeitzerE, UlzP, GeiglJB. Circulating tumor DNA as a liquid biopsy for cancer. Clin Chem, 2015; 61(1):112–123; doi: 10.1373/clinchem.2014.222679.
2.
ZhouC, WuYL, ChenG, et al.Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): A multicentre, open-label, randomised, phase 3 study. Lancet Oncol, 2011; 12(8):735–742; doi: 10.1016/S1470-2045(11)70184-X.
3.
WeiF, LinCC, JoonA, et al.Noninvasive saliva-based EGFR gene mutation detection in patients with lung cancer. Am J Respir Crit Care Med, 2014; 190(10):1117–1126; doi: 10.1164/rccm.201406-1003OC.
4.
PuD, LiangH, WeiF, et al.Evaluation of a novel saliva-based epidermal growth factor receptor mutation detection for lung cancer: A pilot study. Thorac Cancer, 2016; 7(4):428–436; doi: 10.1111/1759-7714.12350.
5.
WeiF, YangJ, WongDT. Detection of exosomal biomarker by electric field-induced release and measurement (EFIRM). Biosens Bioelectron, 2013; 44:115–121; doi: 10.1016/j.bios.2012.12.046.
6.
LiF, WeiF, HuangWL, et al.Ultra-short circulating tumor DNA (usctDNA) in plasma and saliva of non-small cell lung cancer (NSCLC) patients. Cancers (Basel), 2020; 12(8):2041; doi: 10.3390/cancers12082041.
7.
WeiF, StromCM, ChengJ, et al.Electric field-induced release and measurement liquid biopsy for noninvasive early lung cancer assessment. J Mol Diagn, 2018; 20(6):738–742; doi: 10.1016/j.jmoldx.2018.06.008.
8.
TuM, ChengJ, ChenYL, et al.Electric field-induced release and measurement (EFIRM): Characterization and technical validation of a novel liquid biopsy platform in plasma and saliva. J Mol Diagn, 2020; 22(8):1050–1062; doi: 10.1016/j.jmoldx.2020.05.005.
9.
YaoW, MeiC, NanX, et al.Evaluation and comparison of in vitro degradation kinetics of DNA in serum, urine and saliva: A qualitative study. Gene, 2016; 590(1):142–148; doi: 10.1016/j.gene.2016.06.033.
10.
TaoSC, LiY, LiuYH, et al.Room-temperature hybridization of target DNA with microarrays in concentrated solutions of guanidine thiocyanate. Biotechniques, 2003; 34(6):1260–1262; doi: 10.2144/03346mt01.
